{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:55:44Z","timestamp":1792702544041,"version":"4.5.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02112","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T13:09:35Z","timestamp":1599224975000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still\u2019s Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Yue","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuochao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengde","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junna","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease.","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still\u2019s disease.","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1097\/CM9.0000000000000538","article-title":"Pathogenesis, disease course, and prognosis of adult-onset Still\u2019s disease: an update and review.","volume":"132","author":"Wang","year":"2019","journal-title":"Chin Med J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/annrheumdis-2019-215239","article-title":"Both HLA class I and II regions identified as genome-wide significant susceptibility loci for adult-onset Still\u2019s disease in Chinese individuals.","volume":"79","author":"Li","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00898","article-title":"Cytomegalovirus infection may trigger adult-onset Still\u2019s disease onset or relapses.","volume":"10","author":"Jia","year":"2019","journal-title":"Front Immunol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00266","article-title":"Cysteine-rich angiogenic inducer 61 serves as a potential serum biomarker for the remission of adult-onset Still\u2019s disease.","volume":"6","author":"Su","year":"2019","journal-title":"Front Med."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1555-6","article-title":"Interleukin-37 is increased in adult-onset Still\u2019s disease and associated with disease activity.","volume":"20","author":"Chi","year":"2018","journal-title":"Arthritis Res Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3899\/jrheum.140651","article-title":"Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still\u2019s disease.","volume":"41","author":"Bae","year":"2014","journal-title":"J Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17081342","article-title":"TLR4 endogenous ligand S100A8\/A9 levels in adult-onset Still\u2019s disease and their association with disease activity and clinical manifestations.","volume":"17","author":"Kim","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/srep46652","article-title":"Elevated circulating levels of the interferon-gamma-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still\u2019s disease.","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44032-6","article-title":"Histopathology and expression of the chemokines CXCL10, CXCL13, and CXCR3 and the endogenous TLR-4 ligand S100A8\/A9 in lymph nodes of patients with adult-onset Still\u2019s disease.","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03099","article-title":"Plasma microRNA profiles as a potential biomarker in differentiating adult-onset Still\u2019s disease from Sepsis.","volume":"9","author":"Hu","year":"2018","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nbt.1627","article-title":"A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function.","volume":"28","author":"Ozer","year":"2010","journal-title":"Nat Biotechnol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ki.2013.502","article-title":"Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine.","volume":"86","author":"Cheng","year":"2014","journal-title":"Kidney Int."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa5680","article-title":"Urinary metabolic signatures of human adiposity.","volume":"7","author":"Elliott","year":"2015","journal-title":"Sci Transl Med."},{"key":"B16","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease.","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative.","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third International consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3899\/jrheum.100247","article-title":"Clinical manifestations but not cytokine profiles differentiate adult-onset Still\u2019s disease and sepsis.","volume":"37","author":"Rau","year":"2010","journal-title":"J Rheumatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","article-title":"Elevated serum levels of free interleukin-18 in adult-onset Still\u2019s disease.","volume":"55","author":"Girard","year":"2016","journal-title":"Rheumatology."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120483","article-title":"Urinary proteomics for the early diagnosis of diabetic nephropathy in Taiwanese patients.","volume":"7","author":"Liao","year":"2018","journal-title":"J Clin Med."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1800-z","article-title":"Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still\u2019s disease.","volume":"21","author":"Hu","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.59.5.347","article-title":"Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still\u2019s disease.","volume":"59","author":"Vignes","year":"2000","journal-title":"Ann Rheum Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature12345","article-title":"LRG1 promotes angiogenesis by modulating endothelial TGF-beta signalling.","volume":"499","author":"Wang","year":"2013","journal-title":"Nature."},{"key":"B25","doi-asserted-by":"publisher","first-page":"8471","DOI":"10.1073\/pnas.1813212116","article-title":"Conserved serum protein biomarkers associated with growing early colorectal adenomas.","volume":"116","author":"Ivancic","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/ard.2009.118919","article-title":"iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases.","volume":"69","author":"Serada","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1002\/ibd.22936","article-title":"Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis.","volume":"18","author":"Serada","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.7150\/thno.19679","article-title":"Type 1 diabetes: urinary proteomics and protein network analysis support perturbation of lysosomal function.","volume":"7","author":"Singh","year":"2017","journal-title":"Theranostics."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1002\/art.39164","article-title":"Leucine-rich alpha2-glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis.","volume":"67","author":"Fujimoto","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/03009742.2015.1016103","article-title":"Serum leucine-rich alpha2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still\u2019s disease.","volume":"44","author":"Ha","year":"2015","journal-title":"Scand J Rheumatol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1189\/jlb.72.3.478","article-title":"Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation.","volume":"72","author":"O\u2019Donnell","year":"2002","journal-title":"J Leukoc Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1189\/jlb.1107751","article-title":"LRG-accelerated differentiation defines unique G-CSFR signaling pathways downstream of PU.1 and C\/EBPepsilon that modulate neutrophil activation.","volume":"83","author":"Ai","year":"2008","journal-title":"J Leukoc Biol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170261","article-title":"Leucine rich alpha-2 glycoprotein: a novel neutrophil granule protein and modulator of myelopoiesis.","volume":"12","author":"Druhan","year":"2017","journal-title":"PLoS One."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1093\/nar\/13.11.3941","article-title":"Structure of the human alpha 1-acid glycoprotein gene: sequence homology with other human acute phase protein genes.","volume":"13","author":"Dente","year":"1985","journal-title":"Nucleic Acids Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"22174","DOI":"10.1074\/jbc.M109.085464","article-title":"Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation.","volume":"285","author":"Lee","year":"2010","journal-title":"J Biol Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13105-015-0389-9","article-title":"Orosomucoid, an acute response protein with multiple modulating activities.","volume":"71","author":"Luo","year":"2015","journal-title":"J Physiol Biochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"20533","DOI":"10.1002\/jcp.28653","article-title":"Role of acute-phase protein ORM in a mice model of ischemic stroke.","volume":"234","author":"Wan","year":"2019","journal-title":"J Cell Physiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1523\/JNEUROSCI.2534-16.2017","article-title":"Astrocytic orosomucoid-2 modulates microglial activation and neuroinflammation.","volume":"37","author":"Jo","year":"2017","journal-title":"J Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"G305","DOI":"10.1152\/ajpgi.00267.2019","article-title":"Urine alpha-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.","volume":"318","author":"Zhan","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13054","article-title":"Elevated urinary orosomucoid excretion as a novel biomarker in Crohn\u2019s disease.","volume":"49","author":"Szirmay","year":"2019","journal-title":"Eur J Clin Invest."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.7150\/ijms.25687","article-title":"Urinary orosomucoid a potential marker of inflammation in Psoriasis.","volume":"15","author":"Kustan","year":"2018","journal-title":"Int J Med Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1515\/cclm-2016-0840","article-title":"Urinary orosomucoid: a novel, early biomarker of sepsis with promising diagnostic performance.","volume":"55","author":"Kustan","year":"2017","journal-title":"Clin Chem Lab Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.11613\/BM.2016.044","article-title":"Urinary orosomucoid: validation of an automated immune turbidimetric test and its possible clinical use.","volume":"26","author":"Kustan","year":"2016","journal-title":"Biochem Med."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.120","article-title":"Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis.","volume":"48","author":"Park","year":"2016","journal-title":"Exp Mol Med."},{"key":"B45","first-page":"52","article-title":"Clinical features and current treatments of adult-onset Still\u2019s disease: a multicentre survey of 517 patients in China.","volume":"37","author":"Hu","year":"2019","journal-title":"Clin Exp Rheumatol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02112\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T17:00:53Z","timestamp":1668618053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02112\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2020.02112"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02112","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"article-number":"2112"}}